DNAprint Genomics (DNAG)

[frogdreaming]

retro,

I'm not sure I understand the question or how it applies. If you are saying that DNAP cannot go ahead with the distribution of it's unissued stock to Dutchess until the quiet period is over and the registration is approved by the SEC, then I would agree.

However, there has been a significant movement in stock occuring on a daily basis on the open market as a result of the LaJolla distribution and all of those shares are legally available to anyone. Do you find it interesting that even though there is no information available that would prop up the price in the face of quite heavy selling pressure, yet the price decline has been fairly modest under the circumstances.

It would seem that there is some level of buying pressure in play as well. Do you think that Dutchess is constained by these regulations from accumulating on the open market?

I was noticing that in the filing for the Biofrontera deal at the time it was filed, there were still over 700 Million shares left to issue. (Close to half of the authorized number) of those, 300 Million were to be allocated to Dutchess but 400 Million were already destined for LaJolla. Those laJolla shares are definitely in play at this time as evidenced by the latest reports from the transfer agent. Since the filing was announced the OS has increased at a rate that seems to be greater than the pps has dropped. Such behavior seems to indicate buying pressure.

I suppose it is not very cheering to try to see anything positive in the premise that the pps is not falling as fast as it should, but perhaps it is an indicator of something.

regards,
frog